Hepion Pharmaceuticals is Biotechnology in United States that focus on Hepion Pharmaceuticals Inc business. Founded in 2013. They cover business area such as Hepion Pharmaceuticals Inc, drug therapy, chronic liver disease, this therapeutic approach target fibrosis, hepatocellular carcinoma, non-alcoholic steatohepatitis, viral hepatitis, its cyclophilin inhibitor, benefit, these multiple complex pathology, multiple pathologic pathway.
2013
( 11 years old in 2024 )
Hepion Pharmaceuticals Inc
-
399 Thornall Street
1st Floor
Edison, NJ 08837
United States
Private
Hepion Pharmaceuticals Incdrug therapychronic liver diseasethis therapeutic approach target fibrosishepatocellular carcinomanon-alcoholic steatohepatitisviral hepatitisits cyclophilin inhibitorbenefitthese multiple complex pathologymultiple pathologic pathway
* We use standard office opening hours in near Hepion Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Hepion Pharmaceuticals is Biotechnology business from United States that founded in 2013 (11 years old in 2024), Hepion Pharmaceuticals business is focusing on Hepion Pharmaceuticals Inc.
Hepion Pharmaceuticals headquarter office and corporate office address is located in 399 Thornall Street 1st Floor Edison, NJ 08837 United States.
Hepion Pharmaceuticals was founded in United States.
In 2024, Hepion Pharmaceuticals is currently focus on Hepion Pharmaceuticals Inc sector.
Above is snippet of Google Trends for "Hepion Pharmaceuticals Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Hepion Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.